Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OR4F21 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | ENTPD5 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | SYT14 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | CACNA1B | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | UCHL1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | BCL11A | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | NFXL1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | HIVEP3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | CYTH4 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | GCNT2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |